Research News
Jesse Pines, M.D., M.B.A., director of the Center for Healthcare Innovation and Policy Research (CHIPR), as well as other GW CHIPR researchers, created a conceptual model for episodes of acute, unscheduled care. The model, published in Annals of Emergency Medicine, will help researchers,…
Researchers at the GW School of Medicine and Health Sciences and the GW School of Engineering and Applied Science received $1.6 million from the National Heart, Lung, and Blood Institute to study a heart-brain connection that could help the nearly 23 million people suffering from heart failure…
Pedro A. Jose, M.D., Ph.D., professor of medicine and pharmacology and physiology, was elected as chair of the Hypertension and Microcirculation Study Section at the National Institutes of Health.
The International Medicine Programs at the GW School of Medicine and Health Sciences is co-sponsoring a three-day scientific summit with Khon Kaen University in Thailand.
Ferid Murad, M.D, Ph.D., university professor of biochemistry and molecular medicine, and Ka Bian, M.D, Ph.D., M.B.A., associate research professor of biochemistry and molecular medicine, published a paper in The FASEB Journal finding a potential new "wonder drug" for illnesses such as breast…
Urgent Matters, Philips Blue Jay Consulting, and Schumacher Group are now accepting submissions for the 2016 Emergency Care Innovation of the Year Award, a competitive opportunity that fosters innovation in emergency departments nationwide.
WASHINGTON (May 25, 2016) – Shawneequa Callier, J.D., assistant professor of clinical research and leadership in the GW School of Medicine and Health Sciences, is a co-author on a Perspective article featured in the May 26 edition of The New England Journal of Medicine titled, “Will Precision…
David Diemert, M.D., associate professor of microbiology, immunology, and tropical medicine, and Jeffrey Bethony, Ph.D., professor of microbiology, immunology, and tropical medicine, received a $2.2 million grant from the National Institutes of Health to work on a phase 1 clinical trial to…
GW researcher and dermatologist, Adam Friedman, M.D., and colleagues, find that the release of nitric oxide over time may be a new way to treat and prevent acne through nanotechnology.
Researchers at the George Washington University (GW), led by Michael S. Irwig, M.D., found that men referred for tertiary care for borderline testosterone levels had much higher rates of depression and depressive symptoms than those of the general population.